Targeted therapy is an important method in the treatment of lung cancer, especially in the detection of common NSCLC mutations such as epidermal growth factor receptor (EGFR), rat sarcoma viral oncogene (KRAS), anaplastic lymphoma kinase (ALK), and BRAF genes.33 The gene discussed is KRAS; the disease is non-small cell lung carcinoma.